Educational update explains DXA testing, T-scores, fracture-risk factors and questions adults can discuss with ...
Believe it or not, bone loss becomes a significant concern at the ripe old age of … 30. Turns out that building strong, ...
Medically reviewed by Melissa Nieves, LND Key Takeaways Tea may help protect bones and lower fracture risk, especially in ...
FDA Breakthrough Device Designated (BDD) platform engineered for durable fixation in low density boneSANTA CLARA, Calif., ...
Postmenopausal osteoporosis affects hundreds of millions of women worldwide, and current drugs often fall short because they ...
A one-time infusion of sugar-tagged bone marrow cells cut fragility fractures 94% in an osteoporosis trial, pointing toward a potential bone-regeneration treatment.
Si-Bone Inc (NASDAQ:SIBN) shares rose 2.8% in after-hours trading Monday following the company’s announcement that it received U.S. Food and Drug Administration 510(k) clearance for its iFuse Granite ...
In a small study of 10 women, adding sugar to the surface of the patients' own bone marrow cells and administering them ...
SI-BONE stock now carries a USD 25 Jefferies target after the October 5, 2026 upgrade. Q2 revenue reached USD 56.0 million as ...
SI-BONE is redefining spinal fusion with Onyx, an innovation designed to address loosening at the upper and lower instrumented vertebrae (UIV and LIV, respectively) of a spinal fusion construct.
Biodesign brings clinicians, engineers, and other experts together to address real clinical needs, while accounting for regulatory, financial and workflow barriers.